Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

RDHL | Redhill Biopharma Ltd. ADR

Healthcare | Drug Manufacturers - Specialty & Generic | Israel | NASD

Index	-	P/E	-	EPS (ttm)	-3.09	Insider Own	0.50%	Shs Outstand	5.85M	Perf Week	-22.42%
Market Cap	3.64M	Forward P/E	-	EPS next Y	-1.60	Insider Trans	0.00%	Shs Float	5.83M	Perf Month	-31.54%
Income	11.39M	PEG	-	EPS next Q	-	Inst Own	5.91%	Short Float / Ratio	0.10% / 0.01	Perf Quarter	-47.46%
Sales	35.52M	P/S	0.10	EPS this Y	-2566.67%	Inst Trans	-74.75%	Short Interest	0.01M	Perf Half Y	-87.13%
Book/sh	1.18	P/B	0.53	EPS next Y	50.00%	ROA	11.22%	Target Price	7.75	Perf Year	-96.91%
Cash/sh	2.76	P/C	0.23	EPS next 5Y	-	ROE	-847.11%	52W Range	0.61 - 38.40	Perf YTD	-88.90%
Dividend	-	P/FCF	-	EPS past 5Y	15.13%	ROI	255.09%	52W High	-98.38%	Beta	2.04
Dividend %	-	Quick Ratio	0.78	Sales past 5Y	202.65%	Gross Margin	39.59%	52W Low	2.13%	ATR	0.08
Employees	123	Current Ratio	0.96	Sales Q/Q	-90.21%	Oper. Margin	-98.84%	RSI (14)	22.76	Volatility	8.32% 8.02%
Optionable	No	Debt/Eq	0.66	EPS Q/Q	-	Profit Margin	32.07%	Rel Volume	0.12	Prev Close	0.65
Shortable	Yes	LT Debt/Eq	0.29	Earnings	Aug 17 BMO	Payout	-	Avg Volume	398.49K	Price	0.62
Recom	1.00	SMA20	-23.88%	SMA50	-37.89%	SMA200	-84.16%	Volume	49,375	Change	-3.86%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-31-21	Initiated	Cantor Fitzgerald	Overweight	$22
May-18-21	Initiated	H.C. Wainwright	Buy	$23
Sep-11-20	Initiated	BTIG Research	Buy
Jul-12-19	Upgrade	WBB Securities	Buy → Strong Buy
Mar-12-19	Upgrade	WBB Securities	Speculative Buy → Buy
Jan-26-18	Initiated	Nomura	Buy	$18
Oct-06-17	Initiated	Seaport Global Securities	Buy	$19
Oct-04-17	Reiterated	H.C. Wainwright	Buy	$33 → $36
Feb-24-17	Reiterated	FBR & Co.	Outperform	$36 → $25
Jul-27-16	Reiterated	FBR Capital	Outperform	$33 → $36
Sep-29-15	Initiated	Nomura	Buy
Jul-29-15	Reiterated	ROTH Capital	Buy	$30 → $31
Jun-17-15	Reiterated	H.C. Wainwright	Buy	$23 → $32
Jun-15-15	Reiterated	ROTH Capital	Buy	$27.50 → $30

Show Previous Ratings

Sep-22-23 04:15PM	RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
Sep-18-23 07:00AM	RedHill Announces FDA sNDA Approval for Talicia® (PR Newswire)
Sep-05-23 07:00AM	RedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA®) (PR Newswire)
Aug-17-23 07:00AM	RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights (PR Newswire) +13.41%
Aug-01-23 07:00AM	RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. (PR Newswire)
07:00AM	Loading…
Jul-31-23 07:00AM	RedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDA (PR Newswire)
Jul-25-23 03:58PM	RedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercise (PR Newswire)
Jul-21-23 09:33AM	RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds (PR Newswire) -25.95%
07:00AM	RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development (PR Newswire)
Jun-12-23 08:00AM	RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights (PR Newswire)
May-22-23 07:00AM	RedHill Provides R&D Update (PR Newswire)
May-15-23 06:17PM	RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency (PR Newswire)
May-09-23 07:00AM	RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week (PR Newswire)
May-01-23 07:00AM	RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting (PR Newswire) -8.02%
Apr-28-23 07:00AM	RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights (PR Newswire) +6.58%
07:39AM	Loading…
Apr-17-23 07:39AM	Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet (Simply Wall St.)
Apr-11-23 07:00AM	RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -5.76%
Apr-03-23 01:26PM	RedHill Biopharma Announces Closing of $6 Million Registered Direct Offering (PR Newswire)
Mar-30-23 08:00AM	RedHill Biopharma Announces $6 Million Registered Direct Offering (PR Newswire) -6.33%
Mar-23-23 07:32AM	RedHill Biopharma Ltd.'s (NASDAQ:RDHL) market cap dropped US$146m last week; Individual investors bore the brunt (Simply Wall St.) -18.51%
Mar-21-23 07:00AM	RedHill Initiates First Community-Setting Warranty Program to Refund Talicia Non-Responders (PR Newswire)
Mar-16-23 06:15PM	RedHill Biopharma Announces Plan to Implement ADS Ratio Change (PR Newswire)
Mar-08-23 07:05PM	RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor (PR Newswire)
Feb-28-23 08:01AM	RedHill Biopharma Ltd Announces RDHL Opaganib Selected by NIH RNCP For Development (ACCESSWIRE)
07:00AM	RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program (PR Newswire)
Feb-16-23 08:01AM	RedHill Biopharma Ltd Announces RedHill's RHB-102 Positive MHRA Meeting & MAA Plan (ACCESSWIRE) +6.07%
08:00AM	RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorisation Application of RHB-102 (BEKINDA®) for Oncology Support (PR Newswire)
Feb-15-23 07:00AM	RedHill Biopharma Announces Positive FDA Meeting Regarding Opaganib for Acute Nuclear Radiation Syndrome (PR Newswire)
Feb-10-23 03:10PM	Raleigh pharma sheds debt in exchange for top-selling drug. Now what? (American City Business Journals)
Feb-06-23 07:00AM	RedHill Biopharma and HealthCare Royalty Agree to Extinguish All RedHill's Debt Obligations in Exchange for Movantik® (PR Newswire) +12.90%
07:00AM	Loading…
Jan-26-23 07:00AM	RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease (PR Newswire)
Jan-03-23 11:07AM	RedHill Biopharma Shares Jump After Data Publication From COVID-19 Study (Benzinga) +26.16%
07:00AM	RedHill Announces Publication of Positive Phase 2 Study Results with Once-Daily Oral RHB-107 in Non-Hospitalized COVID-19 (PR Newswire)
Dec-27-22 02:53PM	2022 Year in Review: Layoffs hit Triangle biotech, pharma companies (American City Business Journals) -13.06%
Dec-07-22 09:45AM	Aegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for RedHill Biopharma Ltd. (NASDAQ:RDHL) (ACCESSWIRE)
Dec-06-22 01:36PM	RedHill Biopharma Closes $8.0 Million Underwritten Public Offering (PR Newswire) -10.11%
Dec-02-22 09:00AM	RedHill Biopharma Prices $8.0 Million Underwritten Public Offering (PR Newswire) -27.21%
Dec-01-22 04:01PM	RedHill Biopharma Announces Proposed Public Offering (PR Newswire)
Nov-29-22 08:00AM	RedHill Biopharma Announces Q3/22 Results and Operational Highlights (PR Newswire) -6.13%
Nov-24-22 05:19AM	The RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Just Cut Their Revenue Forecast By 23% (Simply Wall St.)
Nov-17-22 08:30AM	RedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation Injury (PR Newswire)
Nov-15-22 03:09PM	RedHill Biopharma set to lose key revenue source, could 'cease operations' (American City Business Journals)
Nov-14-22 08:59AM	RedHill Says Opaganib Has Potential As Nuclear Radiation Protection For Homeland Security Countermeasures (Benzinga)
07:00AM	RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published (CNW Group)
06:00AM	RedHill Biopharma Reaches Agreement in Principle with HCR to Extinguish All Debt Obligations in Exchange for Movantik® (PR Newswire)
Nov-13-22 07:33AM	RedHill Biopharma Second Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-07-22 09:49AM	RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates (PR Newswire)
Nov-04-22 07:00AM	RedHill Presents New Talicia® Data Analyses at Obesity Week 2022 (PR Newswire)
Oct-30-22 08:58AM	RedHill Biopharma Ltd.'s (NASDAQ:RDHL) Path To Profitability (Simply Wall St.)
Oct-27-22 07:45AM	After job cuts, Raleigh drugmaker considers selling lead product (American City Business Journals)
Oct-26-22 07:00AM	RedHill Presents New Talicia® and Movantik® Data Analyses at ACG 2022 (PR Newswire) +6.08%
Oct-20-22 01:08PM	RedHill Biopharma (RDHL) Up on New Patent for COVID-19 Candidate (Zacks) -15.60%
Oct-19-22 12:34PM	RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate (Benzinga) +46.55%
07:00AM	RedHill's Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Patent (PR Newswire)
Oct-18-22 07:00AM	RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
Oct-03-22 11:20AM	RedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5 (Benzinga)
07:00AM	RedHill's Oral Broad-Acting Antivirals, Opaganib and RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5 (PR Newswire)
Aug-18-22 11:04AM	RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug (Zacks)
Aug-17-22 10:12AM	RedHill Biopharma Shares Pop On European Orphan Tag For Lung Disease Candidate (Benzinga) +9.16%
08:00AM	RedHill Biopharma Announces EU Orphan Drug Designation for RHB-204 for NTM Infections (PR Newswire)
Aug-10-22 08:17AM	RedHill Biopharma (NASDAQ:RDHL) investors are sitting on a loss of 89% if they invested five years ago (Simply Wall St.) +6.30%
Jul-12-22 08:00AM	RedHill Announces New H. pylori and COVID-19 Data Publication and Presentations at Leading Upcoming Scientific Conferences (PR Newswire)
Jun-24-22 05:31AM	Raleigh drugmaker slashes workforce as biotech downturn deepens (American City Business Journals) +6.72%
Jun-23-22 01:01PM	RedHill Biopharma Shares Trading Higher On Improved Q1 Profitability (Benzinga)
07:00AM	RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22 (PR Newswire)
Jun-17-22 08:30AM	RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022 (PR Newswire)
May-25-22 09:15AM	RedHill Presents New Talicia® Data Analyses at DDW 2022 (PR Newswire)
May-10-22 07:37AM	Raleigh drugmaker pursuing Covid treatment raising $15M to fund acquisitions (American City Business Journals)
May-09-22 08:30AM	RedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor (PR Newswire) -27.03%
May-06-22 11:20AM	Cathie Woods Latest Portfolio: 10 New Stock Picks in 2022 (Insider Monkey) -6.33%
May-04-22 03:17PM	RedHill Biopharma Ltd. (NASDAQ:RDHL): Is Breakeven Near? (Simply Wall St.)
Apr-14-22 09:55AM	Redhill Biopharma Ltd. (RDHL) Could Find Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Apr-11-22 09:00AM	RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro (PR Newswire) -11.11%
08:02AM	RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib (ACCESSWIRE)
Mar-17-22 07:59AM	RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results (PR Newswire) +24.59%
Mar-15-22 09:00AM	RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea (PR Newswire)
Mar-10-22 07:00AM	RedHill Biopharma to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Webcast on March 17, 2022 (PR Newswire)
Mar-03-22 04:10AM	Shareholders in RedHill Biopharma (NASDAQ:RDHL) are in the red if they invested five years ago (Simply Wall St.) -7.46%
Mar-02-22 04:18PM	COVID SCIENCE-Redhill antiviral shows promise in safety study; J&J shot less effective preventing hospitalization (Reuters)
Mar-01-22 12:00PM	RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients (Benzinga) -10.05%
09:00AM	RedHill Announces Positive Phase 2 Study Results with Oral RHB-107 in Non-Hospitalized COVID-19 (PR Newswire)
Feb-17-22 09:30AM	RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven (PR Newswire)
Feb-07-22 01:38PM	CLARET ASSET MANAGEMENT Corp Buys Bristol-Myers Squibb Co, Shopify Inc, Hertz Global Holdings ... (GuruFocus.com) -5.53%
10:15AM	RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19 (PR Newswire)
Jan-18-22 01:38PM	Henry James International Management Inc. ... (GuruFocus.com)
Jan-13-22 11:51AM	RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance (Benzinga)
10:35AM	RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients (PR Newswire)
Jan-06-22 09:15AM	RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates (PR Newswire)
Dec-20-21 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing (PR Newswire)
08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing (CNW Group)
Dec-15-21 09:16AM	RedHill Announces Additional Insider Buying (ACCESSWIRE)
09:15AM	RedHill Biopharma Announces Additional Insider Buying (PR Newswire)
Dec-14-21 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live December 16th (CNW Group) -5.94%
Dec-09-21 01:05PM	RedHill Biopharma's Talicia Recommended For H. Pylori Infection (Benzinga)
12:19PM	Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th (PR Newswire)
07:33AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
07:15AM	RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori (ACCESSWIRE)
07:00AM	RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication (PR Newswire)
Dec-08-21 10:58AM	Raleigh drugmaker presses forward with potential Covid treatment (American City Business Journals) +7.77%
Dec-06-21 07:01AM	RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations (ACCESSWIRE)

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RDHL | Redhill Biopharma Ltd. ADR

Upgrade your FINVIZ experience